UK ortho industry moves to strengthen EU post-market surveillance

As the future of the EU device regulatory system is being debated in the decision-making institutions of Brussels, the UK orthopedic implants industry is quietly building a scheme in cooperation with the orthopedic profession that could do much to improve confidence in device regulation on a broad scale.

As the future of the EU device regulatory system is being debated in the decision-making institutions of Brussels, the UK orthopedic implants industry is quietly building a scheme in cooperation with the orthopedic profession that could do much to improve confidence in device regulation on a broad scale.

“Beyond Compliance” is a voluntary UK scheme that encourages orthopedic manufacturers to do additional close follow up on their implants,...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight

Quest Diagnostics Minimizes China Tariff Risk With Less Than 1% Supply Chain Exposure

 
• By 

Quest reaffirmed its full-year guidance despite macroeconomic concerns and tariff uncertainty. Revenues are expected between $10.7bn and $10.85bn. Adjusted earnings per share (EPS) is estimated in the $9.55 to $9.80 range for the full year, with EPS between $8.62 and $8.87.

Abbott Launches Next-Gen Delivery System For Proclaim DRG Neurostim

 
• By 

Allen Burton, Abbott’s medical director of neuromodulation told Medtech Insight that the delivery system was developed to make the procedure easier for physicians, especially those who perform the implantations infrequently.

Digital Health Roundup: Synchron Syncs With Apple, Ketryx’s AI Agents, AdvaMed’s AI RoadMap

In this week's Digital Health Roundup, MedTech Insight's Shubham Singh explores how Ketryx's launch of validated AI agents could reshape compliance automation in medtech. Marion Webb highlights news from BCI makers Synchron, Axoft and Subsense. Elizabeth Orr discusses AI advances at the FDA.